Patents by Inventor Ernest B. Izevbigie

Ernest B. Izevbigie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6849604
    Abstract: The present invention provides for a novel anti-neoplastic pharmaceutical composition. Specifically, the present invention provides for phytochemotherapeutic compositions produced from aqueous extracts (and fractions thereof), derived from Vernonia amygdalina leaves. These pharmaceutical compositions inhibit the growth of neoplastic cells, including human breast cancer cells. Furthermore, the instant invention provides for methods of producing the compositions and methods of using the compositions to inhibit the proliferation of neoplastic cells.
    Type: Grant
    Filed: January 13, 2004
    Date of Patent: February 1, 2005
    Assignee: Jackson State University
    Inventor: Ernest B. Izevbigie
  • Publication number: 20040137095
    Abstract: The present invention provides for a novel anti-neoplastic pharmaceutical composition. Specifically, the present invention provides for phytochemotherapeutic compositions produced from aqueous extracts (and fractions thereof), derived from Vernonia amygdalina leaves. These pharmaceutical compositions inhibit the growth of neoplastic cells, including human breast cancer cells. Furthermore, the instant invention provides for methods of producing the compositions and methods of using the compositions to inhibit the proliferation of neoplastic cells.
    Type: Application
    Filed: January 13, 2004
    Publication date: July 15, 2004
    Applicant: JACKSON STATE UNIVERSITY
    Inventor: Ernest B. Izevbigie
  • Patent number: 6713098
    Abstract: The present invention provides for a novel anti-neoplastic pharmaceutical composition. Specifically, the present invention provides for phytochemotherapeutic compositions produced from aqueous extracts (and fractions thereof), derived from Vernonia amygdalina leaves. These pharmaceutical compositions inhibit the growth of neoplastic cells, including human breast cancer cells. Furthermore, the instant invention provides for methods of producing the compositions and methods of using the compositions to inhibit the proliferation of neoplastic cells.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: March 30, 2004
    Assignee: Jackson State University
    Inventor: Ernest B. Izevbigie
  • Patent number: 6541196
    Abstract: The present invention provides for novel methods for measuring the levels of cyclic adenosine monophosphate (cAMP) produced by cells. Notably, the methods provided do not require that the cell membranes be disrupted. Specifically, the present invention provides for a methods of detecting and quantifying cAMP extracellularly and for kits useful in employing these methods. Furthermore the present invention also provides for a method of isolating cAMP produced by cell culture.
    Type: Grant
    Filed: July 23, 2001
    Date of Patent: April 1, 2003
    Assignee: Jackson State University
    Inventor: Ernest B. Izevbigie
  • Publication number: 20020155184
    Abstract: The present invention provides for a novel anti-neoplastic pharmaceutical composition. Specifically, the present invention provides for phytochemotherapeutic compositions produced from aqueous extracts (and fractions thereof), derived from Vernonia amygdalina leaves. These pharmaceutical compositions inhibit the growth of neoplastic cells, including human breast cancer cells. Furthermore, the instant invention provides for methods of producing the compositions and methods of using the compositions to inhibit the proliferation of neoplastic cells.
    Type: Application
    Filed: January 24, 2002
    Publication date: October 24, 2002
    Applicant: JACKSON STATE UNIVERSITY
    Inventor: Ernest B. Izevbigie
  • Publication number: 20020022220
    Abstract: The present invention provides for novel methods for measuring the levels of cyclic adenosine monophosphate (cAMP) produced by cells. Notably, the methods provided do not require that the cell membranes be disrupted. Specifically, the present invention provides for a methods of detecting and quantifying cAMP extracellularly and for kits useful in employing these methods. Furthermore the present invention also provides for a method of isolating cAMP produced by cell culture.
    Type: Application
    Filed: July 23, 2001
    Publication date: February 21, 2002
    Inventor: Ernest B. Izevbigie